Westchester Compounding Pharmacy

• Pharmacy Profile Name: Westchester Compounding Pharmacy
• Website: wc-rx.com
• Location: Westchester County, New York (914 area code)
• Pharmacy Type: 503A compounding pharmacy
• Accreditation: PCAB (Pharmacy Compounding Accreditation Board) accredited
• GLP-1 / Weight Loss: Weight management is an active service area; specific GLP-1 formulations (semaglutide/tirzepatide) not explicitly named in public-facing web content
• Licensed States: Not publicly confirmed; shipping state list listed as “in process” on website
• Telehealth Partners: None publicly named; prescriber-to-pharmacy model

About the Pharmacy

Westchester Compounding Pharmacy describes itself as a home for the best in compounding medications in New York, helping improve the health and well-being of patients and their families with specifically tailored formulations to exacting standards, covering both human and veterinary needs.

The pharmacy prominently displays the PCAB accreditation logo on its website, one of the more meaningful third-party quality designations in the compounding pharmacy space, signaling compliance with PCAB’s standards for sterility, safety, and compounding practice. The pharmacy appears to operate primarily as a prescriber-facing community compounder serving the Westchester County and broader New York metro area.

GLP-1 Compounding

Weight management is listed as an active product category at Westchester Compounding Pharmacy. The pharmacy works with physicians to compound weight loss medications in sublingual, injectable, and transdermal cream forms, including supplements and hormones, to help patients lose weight and maintain results.

Specific GLP-1 formulations, semaglutide and tirzepatide by name, are not explicitly called out in the pharmacy’s current public-facing web content. The weight loss page language reflects a broader, pre-GLP-1-boom compounding practice. Patients and prescribers should contact the pharmacy directly at (914) 200-1222 to confirm current GLP-1 availability and formulation specifics.

Type of Pharmacy

Westchester Compounding Pharmacy is a 503A state-licensed compounding pharmacy operating in New York, with PCAB accreditation. PCAB accreditation is a voluntary distinction that requires pharmacies to demonstrate compliance with USP compounding standards, quality control processes, and sterility protocols. No FDA Warning Letter was found in public records for Westchester Compounding Pharmacy as of March 2026.

States Licensed In

The pharmacy’s “Where We Ship” page was listed as “in process” at the time of research, with no state list published publicly. Based on its New York state presence and community pharmacy positioning, it appears to serve primarily New York-area patients and local prescribers. Multi-state shipping capability should be confirmed directly with the pharmacy before prescribing from out of state.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

Telehealth Providers They Work With

Westchester Compounding Pharmacy works directly with prescribing physicians and offers an e-scribe option for convenience, with prescriptions submitted via phone, fax, or electronic prescribing. No named telehealth brand partnerships were found in public-facing materials. The pharmacy operates on a traditional prescriber-to-pharmacy relationship model.

Pricing from Reviews

No pricing information is published publicly. As a community-oriented 503A compounding pharmacy, pricing would be quoted directly on a per-prescription basis. Patients typically access this pharmacy through their prescribing physician rather than through a direct consumer enrollment process.

Overall Reviews

No significant independent patient review profile was found for Westchester Compounding Pharmacy on Trustpilot, Google, or other third-party platforms as of March 2026, consistent with its community prescriber-facing model rather than a national direct-to-consumer brand. No safety complaints or adverse event reports were found in public records.